Treatment with the recently approved, minimally invasive Optilume BPH device improves urinary symptoms while preserving sexual function in men with benign prostatic hyperplasia (BPH), concludes a ...

Benign Prostatic Hyperplasia Treatment and Management Publication Trend The graph below shows the total number of publications each year in Benign Prostatic Hyperplasia Treatment and Management.

Fox Chase-Temple Urologic Institute is advancing treatment for benign prostatic hyperplasia through new and minimally invasive techniques.

Of the agents that interfere with testosterone's stimulatory effect on prostate size, finasteride, a 5-α-reductase inhibitor, is the only one with FDA-approved labeling for BPH treatment.

Urologic Surgeon, Salim Hawatmeh, discusses signs and symptoms of Benign Prostatic Hyperplasia otherwise known as an Enlarged Prostate & a groundbreaking treatment.

Advice Dear Doctor: What is benign prostatic hypertrophy and what are the common treatments? Published: Aug. 22, 2023, 6:27 a.m.

For patients with benign prostatic hyperplasia (BPH), treatment with α-blockers (ABs) was linked to worse cardiovascular outcomes compared with treatment 5-α reductase inhibitors (5-ARIs).

Learn about Benign Prostatic Hyperplasia, its symptoms, causes, diagnosis and effective treatments to help manage the condition and improve quality of life ...

The "Benign Prostatic Hyperplasia and Prostatitis Devicebased Treatments Market" report has been added to Research and Markets' offering. This analysis includes a discussion of products ...